期刊文献+

康莱特联合DCF化疗治疗晚期胃癌 被引量:1

The application of Kanglaite Combined with DCF on the Chemotherapy of Advanced Gastric Cancer
下载PDF
导出
摘要 目的本研究对康莱特联合化疗和单纯化疗治疗中晚期胃癌的疗效、毒副反应及对生活质量的影响加以比较。方法将96例患者随机分成两组。单纯化疗组(对照组)48例,采用DCF方案:多西他赛35 mg/m2静滴d1,d8;顺铂40 mg静滴d1~d3;氟尿嘧啶750 mg/m2,持续静脉滴注24 h,d1~d5,21天一周期。康莱特联合化疗组(实验组)48例,化疗方案同对照组,化疗第一天开始静脉滴注10%康莱特注射液200 ml,连用10天。两周期治疗结束后对疗效、毒副反应及生活质量进行评价。结果实验组有效率为52%,对照组为33%,两组比较有显著性差异(P<0.05)。两组治疗后的生活质量有显著性差异(P<0.05)。实验组的不良反应发生率低于对照组,发生程度较轻。结论康莱特联合化疗能提高有效率,降低不良反应,改善患者的生活质量。 Objective To explore the efficacy and adverse effects of chemotherapyusing kanglaitecombined with DCF and use DCF alone on the treatment advanced gastric cancer,and the effects on life quantity for patients with gastric cancer.Methods 96 patients with advanced gastric cancer were divided into two groupsrandomly.Patients(n = 48) incontrol groupused DCF treatment program which includingintravenously Docetaxel 35mg / m2at day1 and day8,intravenously cisplatin 40mg at day1 ~ 3,continuously infusion of fluorouracil 750 mg / m2for 24h at day1 ~ 5,3 weeks for a cycle.Patients in experimental group(n = 48) received the program of DCF combined with kanglaite,200ml kanglaitewas given intravenous at the concentration of 10% at the first 10daysfor each chemotherapy cycle.Evaluate the efficacy,toxicity and survival quality.Results Efficiency for experimental group(52%) was significantly higher than thatfor the control group(33%)(P 0.05).The difference of life quality between the two groups was statistically significant(P 0.05).The incidence of adverse reaction in experimental group was lower than that in control group.Conclusions Kanglaite combined with DCF could improve the efficiency,reduce the adverse reactions and improve the life quality for gastric cancer patients receivedchemotherapy.
作者 林锐
出处 《齐齐哈尔医学院学报》 2013年第16期2343-2345,共3页 Journal of Qiqihar Medical University
关键词 胃癌 康莱特 联合化疗 Gastric cancer Kanglaite Combined chemotherapy
  • 相关文献

参考文献9

二级参考文献15

  • 1朱志真,刘国柱,王福江.草酸铂联合氟尿嘧啶并LV治疗晚期胃癌36例效果观察[J].齐鲁医学杂志,2005,20(4):349-349. 被引量:1
  • 2潘启超.长春碱类的新进展──失碳长春碱[J].癌症,1996,15(3):228-231. 被引量:276
  • 3孙燕 周际昌.临床肿瘤内科手册[M].北京:人民卫生出版社,1996.138. 被引量:172
  • 4吴一龙,孙燕.循证医学和临床研究规范[M]//孙燕,赵平.临床肿瘤学进展.北京:中国协和医科大学出版社,2005:3. 被引量:2
  • 5CUNNINGHAM D, ALLUM W H, STENNING S P, et al. Perioperative chemotherapy in operable gastric and lower oesophageal cancer: final results of a randomized, controlled trial (the MAGIC trail, ISRCTN 93793971) [J]. J Clin Oncol, 2005,23 (16S) : 308. 被引量:1
  • 6李玉升.胃癌内科治疗进展[M]//孙燕,赵平.临床肿瘤学进展.北京:中国协和医科大学出版社,2005:738. 被引量:1
  • 7VAN CUTSEM E. The treatment of advanced gastric cancer: new findings on the activity of the taxanes[J]. The Oncologist, 2004,9(2):9. 被引量:1
  • 8PATIENCE P C, KRETZSCHMAR A, REPP M, et al. Do cetaxel and continuous-infusion fluorouacil wersus epirubicin, cisplatin and fluorouacil for advanced gastric cancer adenocarcinoma:phase Ⅱ stady[J]. J Cin Oncol, 2005,23(3):494. 被引量:1
  • 9AJANI J A, VAN CUTSEM E, MOISEYENKO V, et al. Docetaxel (D), cisplatin, 5-fluorouacil compare to cisplatin (C) and 5-fluorouaeil (F) for chemotherapy-native patient with metastatic or locally recurrent, unresectable gastric carcinoma (MAG): interin results of a randomized phase Ⅲ trial (V325)[J]. Proc Am Soc Clin Oncol, 2003,22:999. 被引量:1
  • 10许英爱,李凤龙,JonesSF.一种新型的治疗非小细胞性肺癌的抗肿瘤药长春瑞宾[J].国外医学(药学分册),1997,24(2):82-84. 被引量:46

共引文献140

同被引文献7

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部